Cargando…
Retraction “Methylation of the MAOA promoter is associated with schizophrenia”
Autores principales: | Yang, Hao, Li, Jiajue, Ji, Aicen, Hu, Liping, Zhang, Xiufeng, Liu, Linlin, Qing, Lili, Yan, Ming, Nie, Shengjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729340/ https://www.ncbi.nlm.nih.gov/pubmed/33313300 http://dx.doi.org/10.21037/atm-2020-42 |
Ejemplares similares
-
Retraction: Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis
Publicado: (2023) -
Plasticity of Functional MAOA Gene Methylation in Acrophobia
por: Schiele, Miriam A, et al.
Publicado: (2018) -
Retracted: Correlation of CCNA1 Promoter Methylation with Malignant Tumors: A Meta-Analysis Introduction
por: International, BioMed Research
Publicado: (2021) -
A cross-sectional study on perception of stigma by Chinese schizophrenia
patients [Retraction]
Publicado: (2015) -
Retracted: Efficacy of Risperidone Orally Disintegrating Tablets Combined with Oxazepam in the Treatment of Schizophrenia
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)